Teladoc Health, INC Form 4 insider transactions

Teladoc Health's Chief Legal Officer, Adam C. Vandervoort, reported the conversion of performance and restricted stock units and the subsequent sale of 5,720 shares to cover tax withholding obligations.

Teladoc Health's President, International, Carlos Nueno, reported the acquisition of shares from vested equity awards and a subsequent sale to cover tax withholding obligations.

Teladoc Health's President of U.S. Group Health, Kelly Bliss, reported the vesting and subsequent sale of shares to cover tax obligations from performance and restricted stock units.

Teladoc Health Director Kenneth H. Paulus acquired 10,000 shares of common stock at $6.94 per share through a pre-arranged Rule 10b5-1 trading plan.

Teladoc Health's Chief Accounting Officer, Joseph Ronald Catapano, sold 2,972 shares of common stock to cover tax withholdings following the vesting of restricted stock units.

Teladoc Health Director Jason Eric Evans converted 1,016 restricted stock units into common stock on September 19, 2025, increasing his direct ownership of common shares.

Teladoc Health CEO Charles Divita III reported the vesting of 39,160 restricted stock units into common stock and a subsequent sale of 16,787 shares to cover tax obligations.

Teladoc Health's President, International, Carlos Nueno, sold shares to cover tax obligations following the vesting of performance and restricted stock units.

Teladoc Health's Chief Legal Officer, Adam C. Vandervoort, converted performance and restricted stock units into common stock and subsequently sold a portion to cover tax obligations.

Teladoc Health's President of BetterHelp, Fernando M. Rodrigues, sold shares of common stock in early September 2025, following the conversion of restricted stock units, as part of a pre-arranged 10b5-1 trading plan.

Teladoc Health's President of U.S. Group Health, Kelly Bliss, sold 4,700 shares of common stock to cover tax withholdings following the vesting of equity awards.

Teladoc Health's Chief Financial Officer, Mala Murthy, sold 12,846 shares of common stock to cover tax withholding obligations related to the vesting of performance and restricted stock units.

Teladoc Health, Inc. Director Jason Eric Evans converted 1,016 restricted stock units into common stock on June 20, 2025, as part of a pre-planned vesting schedule.

Teladoc Health, Inc. CEO Charles Divita III reported the conversion of 156,641 restricted stock units into common shares, a routine transaction related to his compensation.

Fernando M. Rodrigues, President of BetterHelp at Teladoc Health, Inc., sold 6,532 shares of common stock in early June 2025, primarily to cover tax obligations and pursuant to a pre-arranged Rule 10b5-1 trading plan.

Teladoc Health's Chief Legal Officer, Adam C. Vandervoort, reported the acquisition of 11,273 shares of common stock through the vesting of performance and restricted stock units, alongside the sale of 5,808 shares to cover tax obligations.

Teladoc Health's President of U.S. Group Health, Kelly Bliss, reported the acquisition of common stock through vesting of performance and restricted stock units, alongside a sale of shares to cover tax obligations.

Teladoc Health's Chief Financial Officer, Mala Murthy, reported the acquisition of shares through vesting of equity awards and a subsequent sale of shares to cover tax withholding obligations.

Teladoc Health's President, International, Carlos Nueno, reported the vesting of restricted and performance stock units and a subsequent sale of shares to cover tax obligations.

Teladoc Health Director David B. Snow Jr. reported the vesting of previously granted restricted stock units into common stock and the acquisition of a new grant of restricted stock units.

Teladoc Health Director Thomas McKinley reported the conversion of 17,467 restricted stock units into common stock and the acquisition of 28,986 new restricted stock units.

Teladoc Health, Inc. Director Mark Douglas Smith was granted 28,986 restricted stock units (RSUs) as part of his compensation, which are set to vest by May 2026.

Director Jason Eric Evans acquired 28,986 restricted stock units in Teladoc Health, Inc. on May 22, 2025, which will vest on the earlier of May 22, 2026, or the day before the 2026 annual meeting of stockholders.

Teladoc Health, Inc. Director Catherine Jacobson converted previously granted restricted stock units into common stock and received a new grant of restricted stock units, as disclosed in a recent SEC Form 4 filing.

Teladoc Health, Inc. Director Kenneth H. Paulus was granted 28,986 restricted stock units (RSUs) on May 22, 2025, as part of his compensation.

Teladoc Health, Inc. Director David L. Shedlarz reported the conversion of previously granted restricted stock units into common stock and the acquisition of new restricted stock units.

Teladoc Health, Inc. Director Sandra L. Fenwick was granted 28,986 restricted stock units on May 22, 2025, as reported in a recent SEC Form 4 filing.

Teladoc Health's CFO, Mala Murthy, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Mala Murthy, CFO of Teladoc Health, reports the acquisition and disposal of company stock and restricted stock units.

Adam Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, reports the acquisition and disposal of common stock and restricted stock units.